Monitoring Tumor Markers in Testicular Cancer Patients
Author Information
Author(s): M.J. Seckl, G.J.S. Rustin, K.D. Bagshawe
Primary Institution: Charing Cross Hospital
Hypothesis
How frequently should serum tumor markers be monitored in patients with non-seminomatous germ cell tumors to prevent poor prognosis?
Conclusion
Weekly monitoring of tumor markers can help initiate treatment before patients develop poor prognostic levels.
Supporting Evidence
- Patients with higher tumor marker levels have worse prognoses.
- Weekly monitoring could prevent 25% of patients from reaching poor prognostic levels.
- Initial weekly marker estimations could lead to at least one additional long-term survivor per 400 patients.
Takeaway
Doctors should check blood markers for testicular cancer patients every week to catch problems early and help them get better.
Methodology
Analyzed records of 64 patients with rising tumor markers and calculated potential time to reach poor prognostic levels.
Limitations
The study did not include patients without a serial rise in markers or those with incomplete data.
Participant Demographics
Patients treated at Charing Cross Hospital between 1968 and 1987.
Want to read the original?
Access the complete publication on the publisher's website